0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1142 results.
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Rituxan (Rituximab) and Biosimilar market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Adalimumab (Humira) and Biosimilar market size is expected to reach $ 16210 million by 2029, rising at a market growth of -4.9% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Enbrel (Etanercept) and Biosimilar market size is expected to reach $ 8122.5 million by 2029, rising at a market growth of 3.2% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
